As of Apr 24
| +0.50 / +7.12%|
The 5 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 18.75, with a high estimate of 28.00 and a low estimate of 11.50. The median estimate represents a +149.34% increase from the last price of 7.52.
The current consensus among 5 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.